Nateglinide

Cat. No.: 0225LY-0828

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Nateglinide is an amino acid derivative used as an oral hypoglycemic agent for type 2 diabetes; it stimulates pancreatic insulin secretion but has been associated with rare cases of acute liver injury.

Synonym: A4166; Senaglinide; 105816-04-4; Starsis; Senaglinide; Fastic; AY-4166; Trazec; A-4166; SDZ-DJN-608; D-Nateglinide; DJN 608; DJN-608; MFCD00875706; (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine; N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine; N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine(Nateglinide Impurity); D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-; D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-; D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-

CAS No.: 105816-04-4

Compound CID: 5311309

Formula: C₁₉H₂₇NO₃

Formula Weight: 317.42

Specification

Relative Density: 1.104 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Nateglinide can be used in endocrinology to study the rapid stimulation of insulin secretion through ATP-sensitive potassium channel closure.